An OBG Management Roundtable

2 HPV vaccines,
7 questions
that you need answered

The availability of two vaccines against human papillomavirus raises numerous questions about fine points of cervical cancer prevention

Dr. Lonky, moderator of this roundtable discussion, is Clinical Professor of Obstetrics and Gynecology at the University of California–Irvine and a member of the Board of Directors of the Southern California Permanente Medical Group. Dr. Lonky serves as a Contributing Editor to OBG Management.

Dr. Lonky reports no financial relationships relevant to this article.

Not long ago (in medical years), we were still trying to discover the cause of cervical cancer. Today, not only do we know that cause to be persistent human papillomavirus (HPV) infection, but we have two vaccines at our disposal to prevent the primary oncogenic strains of the virus.